Cytosorbents Corporation provided earnings guidance for the fourth quarter and full year of 2013. For the quarter, the company expects product sales in the range of $330,000 to $360,000 were a record for the company and represent a greater than 60% sequential increase from the previous Third Quarter 2013, and a greater than 275% increase from the year ago fourth quarter. Gross product margins in fourth quarter of 2013 are expected to exceed 60%.

For the full year, the company expects to report total 2013 revenue of approximately $2.4 million, including both product sales and grant income.